Speaker

Michelle Hoarty

Senior Director, Translational Biomarkers, Dyne Therapeutics

Michelle Hoarty, Senior Director, Translational Biomarkers at Dyne Therapeutics, is speaking at Biomarker Operations & Biospecimen Management Summit (Boston, United States of America, 16–17 Nov 2026) in the session “Managing Post-Trial Sample Disposition & Storage Decisions to Enable Future Research”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

Biomarker Operations & Biospecimen Management Summit
16–17 Nov 2026Boston, United States of America
- SpeakerManaging Post-Trial Sample Disposition & Storage Decisions to Enable Future Research

More speakers at Biomarker Operations & Biospecimen Management Summit

Lokesh Agrawal
Chief (Acting) Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program, National Institute of Health Science
Eduardo Rodriguez Almaraz
Senior Manager, Precision Medicine & Clinical Operations Lead, Regeneron Pharmaceuticals
Karina Bienfait
Executive Director & Head, Consent, Biospecimen & Imaging Management, Bristol Myers Squibb
Bethany Brunton
Associate Director, Biomarker & Diagnostic Operations, Johnson & Johnson
Mine Cicek
Director, Biorepositories Program, Mayo Clinic
Nicole Couture
Director, Biosample Operations, Arcus Biosciences

See all 25 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Michelle Hoarty, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].